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Simian virus 40 (SV40) large T antigen is a multifunctional protein which plays central roles during both
lytic and transforming infections by SV40. It is a potent transcriptional activator and increases expression
from the SV40 late promoter and from several cellular promoters. To understand better the transcriptional
activation activity of large T antigen, we examined its ability to transactivate a set of simple modular promoters
containing one of four upstream activation sequences coupled with one of three different TATA box sequences
originally constructed and studied by Taylor and Kingston (Mol. Cell. Biol. 10:165-175, 1990). Large T antigen
activated transcription from all of these simple promoters. The identity of the TATA box was a more important
determinant of the final level of gene expression than was the identity of the upstream activating sequence
element. We also determined the ability of a set of mutant SV40 large T antigens to activate a subset of these
promoters. Several mutant SV40 large T antigens which had reduced ability to activate the complex SV40 late
and Rous sarcoma virus long terminal repeat promoters showed reduced transcriptional activation activity on
all of the modular promoters tested. We used a set of promoter derivatives of the human U6 small nuclear RNA
promoter containing different TATA boxes and found that wild-type large T antigen could activate transcrip-
tion from all of them, although to widely different levels of expression.
The simian virus 40 (SV40) large T antigen performs many
essential functions during the life cycle of the virus (for a
review, see reference 21). Biochemical studies have shown that
T antigen binds specifically to sequences within the SV40
origin of DNA replication region and nonspecifically to other
DNA molecules. T antigen also possesses ATP-binding and
ATPase activities, and both are required for T antigen to
function as a helicase. It is through these multiple biochemical
activities and interactions with the cellular DNA replication
machinery that T antigen catalyzes viral DNA replication in
permissive primate cells; T antigen brings about the oncogenic
transformation of many mouse and rat cell lines and can also
immortalize primary rodent embryo fibroblasts. These alter-
ations in growth control do not require DNA binding, ATP
binding, ATPase activity, or helicase activity (66, 69).
T antigen also controls transcription. Through binding to
sequences in the origin of DNA replication, T antigen re-
presses transcription from the SV40 early promoter (2, 46, 49,
50). Mutants defective for DNA binding are also defective for
this autoregulation. During the lytic infection cycle, T antigen
stimulates transcription from the SV40 late promoter in a
process that does not require T antigen binding to viral DNA
(10, 11, 33, 34). In addition, SV40 infection causes a large
increase in the concentration of several cellular proteins
involved in nucleotide metabolism and DNA replication, in-
cluding DNA polymerase alpha, thymidine kinase, thymidylate
synthetase, and dihydrofolate reductase (for a review, see
reference 60). Transcriptional stimulation by T antigen may
underlie these enzyme inductions, which are part of a general
program whereby T antigen stimulates resting cells to enter the
cell cycle and progress to the S phase so that viral DNA
replication can occur.
In its roles as a transcriptional activator, T antigen resembles
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the E IA proteins of the human adenoviruses (for a review, see
reference 23). Related proteins of 243 and 289 amino acids are
the primary products of the adenovirus EIA gene and are
encoded by 12S and 13S EIA mRNAs, respectively. Both
proteins display transcriptional activation activity. The EIA
proteins interact with plO5Rb and the related p107 protein
(62, 63), each of which also forms complexes with cellular
transcription factor E2F (5-7, 13, 16, 52). T antigen and the
growth-regulating E7 protein of the human papillomaviruses
also form complexes with pl(5Rb and p107 (18-20, 44).
Complex formation between these tumor virus proteins and
plO5Rb or p107 releases E2F (4), permitting E2F to stimulate
transcription of genes containing E2F-binding sites. E2F-
binding sites are found in several genes important for cellular
growth control, including c-myc, N-myc, c-mnyb, thymidine
kinase, and dihydrofolate reductase (30, 31, 43). In addition,
E1A proteins can interact directly with the TATA boxbinding
protein (TBP), the component of transcription factor TFIID
involved in direct binding to the TATA box (37). It is this
interaction which may be central to ElA's ability to activate
transcription from a range of modular promoters containing
different TATA boxes coupled with different upstream tran-
scription factor-binding sequences (57, 58).
Most studies of transcriptional activation by T antigen have
used the SV40 late promoter, the Rous sarcoma virus (RSV)
long terminal repeat promoter (LTR), or the adenovirus E2
promoter (1, 10, 40, 54, 68). The SV40 late promoter lacks a
TATA box, while the others contain this motif. None of the
other sequence elements required for efficient transcription of
these promoters are shared. Thus, the mechanisms by which T
antigen stimulates transcription are not known. Gruda et al.
showed that TBP also interacts with SV40 large T antigen (27).
Their studies also demonstrated a correlation between the
ability of fragments of T antigen to interact with the TBP and
their ability to activate transcription from the SV40 late
promoter.
We previously examined the ability of a set of SV40 large T
antigen mutants to activate transcription from the SV40 late
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and RSV LTR promoters (68). We found that a 138-amino-
acid N-terminal fragment of T antigen retained the ability to
trans activate both promoters at 30 to 50% of the level of
transactivation by the wild-type T antigen. Several mutants
with lesions within the first 85 amino acids of T antigen were
partially defective for trans activation of the RSV LTR, and
most of these were also partially defective for trans activation
of the SV40 late promoter. Thompson et al. (59) examined the
ability of a set of mutant T antigens lacking 109 to 176
N-terminal residues to activate the adenovirus E3 promoter
and found that these mutant T antigens retained trans activa-
tion activity. This suggests that T antigen contains multiple
domains that function to activate transcription. Different acti-
vating domains may operate through different mechanisms.
To examine further the transcriptional activation function of
T antigen, we measured the responses of several promoter
constructs to activation by the SV40 large T antigen. We
employed the set of modular promoters used by Taylor and
Kingston to examine trans activation by ElA (57, 58). These
simple promoters contain combinations of one of four different
upstream activating sequences (UASs) coupled with one of
three different TATA box sequences. We found that T antigen
was able to activate all of these constructs and that the identity
of the TATA box was more important for the final level of
gene expression than was the type of UAS. We also measured
the abilities of several mutant T antigens to activate a subset of
these modular promoters. Mutants which had reduced ability
to activate the SV40 late and RSV LTR promoters also
showed reduced trans activation activity on all of the modular
promoters analyzed. In addition, we used a set of constructs
based on the human U6 small nuclear RNA (snRNA) pro-
moter (39). We found that T antigen was able to activate
almost all of the promoter variants tested, but a wide range in
the level of activation was seen among this set of simple
promoters. Possible mechanisms by which T antigen affects
transcription are discussed.
MATERIALS AND METHODS
Plasmids and SV40 mutants. Transformation of bacterial
cultures (41), analysis of minilysate preparations of DNA (9),
and large-scale preparation of purified plasmid DNA (51) were
performed by using established methods. All plasmids were
propagated in Escherichia coli HB101.
(i) Reporter plasmids and RNase protection probe. The
RNA polymerase II promoter plasmids (see Fig. 1) were kindly
provided by I. Taylor and have been described previously (58).
In these plasmids, the bacterial chloramphenicol acetyltrans-
ferase (CAT) gene is located downstream from a set of
modular promoters containing different TATA boxes in com-
bination with different UASs. The plasmid set bearing altered
U6 promoters (see Fig. 4) have also been described previously
(38, 39), as has the plasmid used to make RNase protection
probe phU6/RA.2/198. These were kindly provided by N.
Hernandez.
(ii) Plasmids that contain wild-type and mutant SV40 early
regions. Most of these plasmids and the mutants they encode
have been described previously (53, 61, 67, 68). All of the
plasmids containing SV40 genomes, except mutant 153NS
(53), had a 6-bp deletion at the BglI site within the origin of
DNA replication, rendering them replication defective without
affecting the level of T antigen expression. Mutant inA2835
contains an insertion of 9 bp causing replacement of thr-85 and
tyr-86 with Ile-Ala-Ile-Ala-Asn. Mutant inA2819 contains a
12-bp insertion at the position of amino acid 346 causing
replacement of Ala-346 with the sequence Val-Ala-Ile-Ala-
Thr. Mutant d/A2834 has a deletion of the central 3 bp of the
PflMI site at nucleotide (nt) 4558. Mutant d/A2420 has a
deletion of 20 bp that causes a frameshift following amino acid
(aa) 138 and addition of Leu-Glu-Ser-Cys-Cys-Val following
Phe-138. Mutant dlA2411 has a 12-bp deletion which removes
aa 143 to 146. Mutant dlA2831 has a deletion of aa 4 to 34. The
mutant 153NS T antigen contains Ser in place of Asn-153.
Mutant d1888 (14) is a viable mutant with a deletion that
removes part of the splice donor site for the early mRNA that
encodes small t antigen; it produces only large T antigen. The
153NS point mutation (53) and the d1888 deletion (14) were
combined by exchanging PflMI fragments, and the resulting
mutant is designated 153NS/dl888.
Transactivation assays. CV-1 monkey kidney cells were
maintained in Dulbecco's modification of minimal essential
medium (GIBCO) supplemented with 10% newborn calf se-
rum (Hyclone, Logan, Utah) and antibiotics. Transactivations
were performed in duplicate for each condition tested, and
each experiment was performed twice. Transactivation assays
were performed by cotransfecting cells with 4.0 jig of a plasmid
that encodes wild-type SV40, 0.5 ,ug of a reporter plasmid, and
15.5 ,ug of salmon sperm DNA. We used the calcium phos-
phate method to introduce DNAs into cells (25). To monitor
transfection efficiency, we included in a parallel plate a control
transfection with pSV2APAP DNA (29), which encodes pla-
cental alkaline phosphatase. After 45 h, cells expressing pla-
cental alkaline phosphatase were detected histochemically by
using naphthol AS-MX phosphate alkaline solution and fast
violet B (both from Sigma Chemical Co., St. Louis, Mo.) as
directed by the manufacturer. At the same time, we also
prepared extracts of transfected cells. Cells were washed twice
with TS (25 mM Tris HCl [pH 7.5], 137 mM NaCl, 5 mM KCl,
0.6 mM Na2HPO4, 0.05 mM MgCl2, 0.7 mM CaCl2), scraped
off the plates with a cell scraper in the presence of 1.0 ml of TS,
centrifuged briefly in a microcentrifuge, suspended in RSB (10
mM Tris HCl [pH 7.35], 10 mM NaCl, 1.5 mM MgCl2 [pH
7.35]) containing 0.4% Nonidet P-40, and incubated at 0°C for
30 min. The nuclei were pelleted, and the supernatant contain-
ing the CAT enzyme was carefully removed.
To assay the amount of CAT enzyme present in each
sample, we used a modification of the method of Neumann et
al. (45). This assay uses 3H-labeled acetyl coenzyme A (acetyl-
CoA) and measures direct diffusion of the labeled product
(acetylated chloramphenicol) into water-immiscible liquid
scintillation counting fluid (Econofluor; Dupont). Only the
acetylated derivatives of chloramphenicol are able to enter this
organic phase. Portions of extracts were added to 100 ml of
CAT reaction buffer (125 mM Tris HCl [pH 7.8], 2.5 mCi of
3H-labeled acetyl-CoA [200 mCi/mmol; Dupont, Boston,
Mass.] per ml, 1.25 mM chloramphenicol). Since chloramphen-
icol was present in large excess, compared with the concentra-
tion of 3H-labeled acetyl-CoA, the initial rate of acetylation of
chloramphenicol was proportional to the concentration of
3H-labeled acetyl-CoA and the rate constant was a measure of
the amount of the CAT enzyme present in each extract.
Because all of the CAT reactions were conducted with the
same concentration of 3H-labeled acetyl-CoA, the only mea-
surements required were elapsed time since the acetylation
reaction began and amount of radioactivity in the scintillation
fluid. In practice, a set of samples was each counted for 0.1 min
several times during a 4-h period, and these data were plotted
against elapsed time. Background radioactivity was subtracted,
and the rate constants were calculated. This method was
standardized and validated by use of a range of concentrations
of the purified CAT enzyme (Sigma). When using CAT
enzyme, the same results were obtained whether or not an
J . VlIROL.
TRANSACTIVATION OF MODULAR PROMOTERS BY SV40 T ANTIGEN 6691
aliquot of an extract from a mock-transfected culture was
added to the reaction mixture.
To determine the amount of reporter plasmid DNA present
in transfected cell cultures, the nuclear pellet was solubilized
by addition of Hirt solution (0.1 M Tris HCl [pH 7.5], 0.6%
sodium dodecyl sulfate [SDS], 0.1 M EDTA) (32) and the
plasmid DNA was separated from chromosomal DNA by
centrifugation at 4°C in an Eppendorf 5413 centrifuge. The
supernatant, containing low-molecular-weight episomal DNA,
was phenol extracted, depurinated in 0.25 M HCl for 3 to 5
min, denatured in 0.6 M NaOH and 1.5 M NaCl, neutralized
with 1 M Tris HCl (pH 7.0)-1.5 M NaCl, and applied to
nitrocellulose membranes with a slot blot apparatus
(Schleicher & Schuell, Inc., Keene, N.H.). The membrane was
baked in vacuo for 1 h at 80°C. The amount of the reporter
plasmid DNA in each sample was determined by hybridization
of the membrane to a CAT-specific probe made by oligo
labeling (22) a twice gel-purified 529-bp SacI-BamHI fragment
containing part of the CAT protein-coding region. The purity
of the probe was tested by hybridization to known quantities of
either pURSVCAT (the CAT gene under control of the RSV
LTR) or p6-1 (origin-defective SV40 cloned into pUC18). The
signal generated with p6-1 was less than 0.5% of the signal
generated with an identical amount of pURSVCAT DNA.
Autoradiograms of the slot blots were quantitated by using a
MasterScan Interpretive Densitometer (Scanalytics, Division
of CSP, Inc., Billerica, Mass.).
RNase protection analysis. Cells were washed with cold RSB
and lysed by addition of RSB containing 0.4% Nonidet P-40
and 0.05% deoxycholate. A portion was removed for determi-
nation of the reporter plasmid DNA concentration by the Hirt
lysis method (32, 68). One milliliter of 2 x RNA buffer (500
mM NaCl, 50 mM Tris HCl [pH 8.0], 12 mM EDTA) was
added to the remainder of the lysate. This was extracted twice
with phenol-chloroform (1:1) and then ethanol precipitated.
To synthesize the probe for RNase protection, pHU/RA.2/
198 DNA was linearized with EcoRI and transcribed by using
T3 RNA polymerase to produce a transcript of 531 nt. For the
sizes of the regions of the probe protected by hybridization
with different potential U6 snRNA construct transcripts, see
Fig. 4b; they were 393 nt for a transcript which initiates from
the U6 promoter and terminates at the L3 3' end [adenovirus
L3 poly(A) signal], 198 nt for a transcript which initiates from
the U6 promoter and terminates at the run of T residues
characteristic of an RNA polymerase III termination site, and
143 nt for a transcript which initiates from the U6 promoter
and terminates at the snRNA 3' box.
An experimentally determined excess of the probe was
mixed with 20 jig of RNA in a total volume of 30 ,ul of
hybridization buffer [40 mM piperazine-N,N'-bis(2-ethanesul-
fonic acid) PIPES; pH 6.5), 400 mM NaCl, 1 mM EDTA, 80%
deionized formamide], heated to 90°C for 10 min, and placed
at 61°C overnight. Annealing was halted by addition of 300 Il
of cold RNase digestion buffer (10 mm Tris HCl [pH 7.5], 5
mM EDTA, 300 mM NaCl) containing 200 U of RNase T1 per
ml, and samples were placed at 37°C for 1 h. Samples were
phenol-chloroform extracted, ethanol precipitated, collected,
dissolved in sample buffer, and analyzed by electrophoresis on
a 4% polyacrylamide-7 M urea gel. After electrophoresis, the
gel was dried and autoradiographed.
The amount of the reporter plasmid present in each culture
was determined, as described above for the CAT plasmids, by
using the same T3 transcript used for RNase protection
analysis as a hybridization probe. The amount of the U6
transcript in each culture was determined by densitometry of
the autoradiograph with a MasterScan Interpretive Densitom-
-70 -60 -50 -40 -30 -20 -10 +1
UPSTREAM~ maz-T~~ l~ TATA s~-oi- --~CA
CAATT GATTGGCT HSP70 ACTTATAAAAG
ATF TGACGTCA SVE TTTTATTTATG
SP1 GGGGCGGGGC Ad Ella CCTTAAGAGTC
AP1 TGAGTCAG TATA NS TAGGCAGTCCA
UpNS TAGGCAGT
FIG. 1. Structure of the RNA polymerase II modular promoter
constructs. The gray bar represents sequences from the human HSP70
promoter, and the white bar represents CAT-coding sequences. The
transcription factor recognition sequences that have been placed
between - 60 and - 68 are indicated below the upstream region. The
TATA region sequences are indicated below the diagram, between
- 20 and - 31. The arrow indicates the direction of transcription. Ad,
adenovirus.
eter, and these values were normalized for the amount of the
reporter plasmid present in that culture.
RESULTS
Previous studies of transactivation of transcription by SV40
large T antigen have examined either the wild-type SV40 late
and early promoters (11, 33, 34, 64, 68) or reporter genes
under control of other complex cellular and viral promoters (1,
68). To begin examining the mechanisms by which T antigen
stimulates transcription, we tested the ability of the wild-type
large T antigen to transactivate a set of modular promoters
generated by Taylor and Kingston (55, 57, 58). The organiza-
tion of these modular promoters is shown in Fig. 1. They were
derived from the human heat shock protein 70 (HSP70)
promoter altered to remove upstream sequences including
heat shock response elements. This left the basal HSP70
promoter containing an upstream CAATT box and the HSP70
TATA box. Substitutions of this construct were made at both
the CAATT box and the TATA box to generate a set contain-
ing different upstream elements and different TATA boxes. By
combining these elements pairwise, a set of 20 constructs was
produced. These contain as the UAS either the HSP70
CAATT box; sites recognized by ATF, SP1, or AP1; or a
nonsense sequence not recognized by any known transcription
factor. In addition to the HSP70 TATA box, TATA box
sequences from the SV40 early promoter and the adenovirus
E2A promoter were used, as well as a nonsense sequence in
place of any TATA box. Downstream from all 20 constructs
was the bacterial CAT gene.
We cotransfected CV-1 monkey kidney cell cultures with a
plasmid containing the early region from SV40 and one of the
reporter plasmids. Other cultures received only the reporter
plasmid plus carrier DNA. CAT activity was determined in
extracts prepared 45 h after transfection. We also determined
the amount of the reporter plasmid DNA taken up into each
culture and used this value to normalize CAT activity data. The
results from multiple experiments are displayed in Fig. 2. The
bar graphs present CAT activity normalized for the amount of
reporter plasmid DNA. Each set of bar graphs presents the
CAT activity present in cultures lacking (-) or containing (+)
wild-type T antigen. We noted that the SV40 plasmid used in
these studies also encodes small t antigen; we saw no effect
from small t antigen in transactivation experiments (see Fig. 5;
48). The inset in Fig. 2 presents the average fold induction
obtained with the SV40 T antigen.
With all of these constructs, very little CAT activity was
detected in the absence of SV40 T antigen. T antigen was able
to activate expression from almost all of these modular pro-
moters, but to various degrees. Regardless of which UAS was
used, the greatest activity was always seen with the HSP70
TATA box. The adenovirus E2A TATA box could be com-
VOL. 67, 1993
6692 RICE AND COLE
UAS- CCAAT ATF Sp1 Ap1 NS
Tag: + - + + + +
FIG. 2. The level of induction of CAT activity induced by wild-type
T antigen (Tag) depends primarily on the TATA region. CAT activity
was determined as described in Materials and Methods. The error bars
indicate the standard deviation of the mean (n = 4). Bar patterns
indicate the TATA region in the construct in accordance with the key
at the right. The UAS used is indicated along the x axis, and the
presence or absence of SV40 large T antigen is indicated by a plus or
minus signs, respectively. The inset shows fold induction of CAT
activity from each promoter by SV40 large T and small t antigens. Data
from the bar graph are represented as fold stimulation of basal activity
(i.e., CAT activity of the construct in the presence of SV40 T antigen
divided by the uninduced level of CAT activity of that construct).
bined with each of the UASs to yield promoters which could be
activated by SV40 T antigen but to CAT levels lower than
those obtained with the HSP70 TATA box. In contrast, very
little CAT activity was produced when the SV40 early TATA
box was coupled with each of the different UAS elements. In
fact, CAT activities detected when using the SV40 early TATA
box promoters were usually only slightly greater than those
obtained with the nonsense TATA sequence. Regardless of the
level of CAT detected in cultures lacking SV40 T antigen,
there was substantial stimulation of CAT activity in the
presence of T antigen. Most of the constructs were stimulated
10- to 40-fold by T antigen. These data indicate that T antigen
is able to stimulate expression from a wide variety of modular
promoters containing one of four different UASs and one of
three different TATA box variants.
We wondered whether mutants that showed a partial defect
in activation of complex promoters, such as the SV40 late
promoter and the RSV LTR, would show wild-type activity on
some simple promoters and a lack of activity on others.
Alternatively, mutant T antigens with partial activity on com-
plex promoters might show reduced activity on all simple
modular promoters. Therefore, we examined the ability of
mutant SV40 T antigens to activate a subset of these modular
promoters. We limited this analysis to modular promoters
containing the HSP70 TATA box. The results of this study are
shown in Fig. 3. Note that the data represent the fraction of the
wild-type level of activation seen with each mutant T antigen
on each reporter promoter tested. In general, the mutants
tested gave the same relative level of activity on all five
modular promoters. Thus, mutants which showed a partial
defect in transactivation of complex promoters retained that
partial transactivation activity when tested on simple promot-
ers.
We extended our studies by testing a set of constructs
FIG. 3. Transactivation activity on modular promoters of SV40 T
antigen mutants. Cells were cotransfected with the subset of modular
promoters containing the HSP70 TATA box and different upstream
elements. Note that the CAT activity obtained in response to each
mutant T antigen is expressed as a percentage of the activity seen with
wild-type (WT) large T antigen acting on the same modular promoter.
prepared and used by Lobo et al. to study the human U6
snRNA promoter (39). The structures of these constructs are
illustrated in Fig. 4. They contain the U6 TATA box, one of six
TATA box variants, or a linker in place of the normal TATA
box (LS7). All of the constructs contain the normal U6 snRNA
gene sequences upstream of the TATA box region. These
promoters drive transcription of an antisense human ,B-globin
RNA which was detected by RNase protection analysis. Down-
stream of the globin insert are the normal 3' box used for
3'-end formation of snRNAs generated by polymerase II
transcription, an RNA polymerase III termination signal
(TFTT), and a polyadenylation signal. Depending on which of
these elements signals 3'-end formation, the portion of the
probe protected from RNase treatment differs, as depicted in
Fig. 4b.
We tested activation of these promoters by two different
T-antigen constructs. Mutant 153NS was used as a pseudowild-
type. It contains a point mutation resulting in a change of
Asn-153 to Ser; the 153NS T antigen lacks DNA-binding and
viral DNA replication activities (53) but transactivates expres-
sion from the RSV LTR and SV40 late promoters, as well as
wild-type T antigen (data not shown). It was used in place of
wild-type SV40 T antigen to prevent replication of the U6
snRNA constructs, all of which contain a functional SV40
origin of replication. The validity of using this mutant as a
pseudowildtype was confirmed by comparing transactivation in
cells which received a reporter plasmid and mutant 153NS with
those which received the same reporter, a wild-type large T
antigen plasmid, and a concentration of cytosine arabinoside
(25 ,ug/ml) sufficient to inhibit viral DNA replication com-
pletely. The same level of transactivation was seen in both
cultures (data not shown). Mutant 153NS also encodes a
wild-type small t antigen. 153NS/d1888 contains a deletion of
the splice donor site for small t mRNA; therefore, it produces
pseudowildtype large T antigen (153NS) but no small t antigen.
CV-1 cells were transfected with a U6 snRNA plasmid and
either 153NS, 153NS/d1888, or no SV40 plasmid. Total cyto-
plasmic RNA and low-molecular-weight DNAs were each
isolated 45 h after transfection. RNAs were analyzed by RNase
protection analysis, and the results are shown in Fig. 5A.
Controls were performed to ensure that this analysis was done
with an excess of probe. The amount of RNA detected was
calculated densitometrically and normalized for the amount
of the reporter plasmid in each culture. The wild-type U6
promoter was efficiently activated by T antigen (Fig. 5A,
J V IROL.
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probe: U6/RA.2/198 531 -
FIG. 4. Constructs derived from the human U6 snRNA gene. (a) Detail of the promoter-proximal region. The gray bars represent U6
sequences. The cross-hatched portion indicates sequences that direct transcription by RNA polymerase III. For the TATA region, mutations are
indicated as changed nucleotides below the diagram. The names of the constructs are to the right and indicate the TATA regions that the mutant
sequences match. (b) Structural features of the U6 promoter constructs. OCTA is an octamer-binding sequence, PE is the proximal element
represented by the hatched box in panel a, and T/A is the TATA region. The RNase protection probe and protected fragments are indicated below
the illustration of the construct.
lane 3), and a similar level of activation was detected in the
presence of both small and large T antigens (lane 2). The
presence of only the 143-nt band indicates that all transcription
from the wild-type U6 promoter used the 3' box associated
with polymerase II transcription and the normal signal for
3'-end formation of snRNAs. Little expression of RNA or
activation by T antigen was seen in constructs containing a
linker in place of the TATA box (lanes 4 to 6) or containing
two point mutations in the TATA box (lanes 7 to 9). Of the
other TATA boxes tested, the greatest activation was seen with
the HSP70 TATA box (lanes 13 to 15) and the adenovirus E4
TATA box (lanes 19 to 21). A very low level of activation was
seen with the adenovirus major late promoter TATA box
(lanes 10 to 12), and a slightly greater level of activation was
seen with the SV40 early TATA box (lanes 16 to 18). In some
situations, a higher level of activation appeared to occur with
SV40 large T antigen alone, while with others, a higher level
appeared to occur when both small and large T antigens were
present than when only large T antigen was present. We do not
believe that these differences are significant. In a repeat of this
experiment, we again saw the greatest activation of promoters
with the HSP70 and adenovirus E4 TATA boxes, lower
activation with the SV40 early and U6 wild-type TATA boxes,
little activation of the adenovirus major late TATA box, and
very little activity on the LS7 and DPM constructs. In most
cases, the activities of large T antigen alone and of small and
large T antigens together were similar (data not shown). It has
been reported that the small t antigen can assist large T antigen
in activation of gene expression under conditions of limiting
levels of large T antigen (8). The level of the large T antigen in
cells transfected by either 153NS/d1888 or 153NS was near the
level obtained in virus-infected cells (data not shown). In
several experiments, we have not found reproducible differ-
ences in activation of reporter genes by the large T antigen
compared with the small t and large T antigens together (48).
DISCUSSION
Our studies indicate that large T antigen is able to activate
a variety of modular promoters containing different UASs and
different variants of the TATA box. In comparing different
simple modular promoters (Fig. 2), it is important to consider
both the level of CAT expression achieved with different
promoters and the fold induction by SV40 large T and small t
antigens. In all cases, the highest level of induction was seen
with the HSP70 TATA box; lower levels were obtained with
the adenovirus E2A TATA box. The level of CAT expression
obtained with the SV40 early TATA box or when a non-
TATA-like sequence replaced the TATA box was very low.
Fold induction by T antigen followed a different pattern. When
the very inefficient SV40 early TATA construct containing a
nonsense sequence was used in place of a UAS as a baseline,
all other constructs were activated by T antigen, with a range of
7- to 94-fold. Among those constructs with the highest fold
induction were some which contained a non-TATA sequence
in place of the TATA box. While we believe that T antigen
does activate these constructs, the very low levels of expression
in the absence of a transactivator make the fold induction
numbers less accurate. Similarly, the fold induction observed
with many of the other constructs reflects as much the differ-
ences in basal levels of expression as it does the differences in
final levels of CAT expression. We conclude that T antigen is
able to activate a variety of simple modular promoters.
The critical question that needs to be answered is the
mechanism of transcriptional activation by SV40 T antigen.
Since T antigen activates promoters containing many different
UAS elements, we think it unlikely that T antigen transactiva-
tion is mediated primarily by direct interactions between T
antigen and proteins that bind to UAS elements, since this
would require that T antigen be able to interact with multiple
proteins containing different types of activation domains. More
likely, transactivation by T antigen involves interactions be-
tween T antigen and components of the basic transcription
machinery. T antigen could affect interactions between TBP
and DNA, since the T antigen is known to bind TBP (27).
Alternatively, T antigen could affect the recruitment to or
retention in the transcription complex of some factor other
than TBP. Gruda et al. have suggested that T antigen mediates
transcriptional activation by interacting both with components
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FIG. 5. RNase protection analysis of transcription from pHU6
promoter constructs. (A) Autoradiograph of a 4% polyacrylamide gel
showing RNase protection analysis of transcription from U6 promoter
constructs. The positions of size markers are shown at the left and
right. Lanes marked with minus signs contained cultures which re-
ceived only a U6 snRNA construct. Lanes T/t also contained pseudo-
wild-type mutant 153NS. Lanes T also contained SV40 mutant 153NS
d1888. (B) Histogram showing normalized values for RNA levels from
the autoradiograph. The autoradiograph in panel A was analyzed
densitometrically, and the resulting data were normalized for the
amount of the reporter plasmid present in each culture. wt, wild type;
Ad, adenovirus; ML, major late promoter.
recognize UASs and, in so doing, may stabilize the transcrip-
tion complex (27). Our data are consistent with this mecha-
nism.
It is not known whether T antigen-TBP complexes form
following binding of the TBP to a TATA box or whether a T
antigen-TBP complex forms in solution and subsequently binds
to the TATA box. If T antigen binds to TBP already bound to
DNA, this interaction could stabilize TBP binding to different
extents with different TATA boxes. Since TBP is thought to
remain bound to DNA through multiple rounds of initiation by
RNA polymerase II, the rate of dissociation ofTBP from DNA
could be a significant factor in determining how many rounds
of transcription are initiated following assembly of the basal
transcription complex. However, it is not known whether
binding of TBP to DNA is the rate-limiting step in initiation
nor whether TBP binds different TATA boxes with different
affinities. Since a wide range of sequences can function as
TATA boxes, at least in Saccharomyces cerevisiae (ref), it is
likely that TBP has different affinities for different TATA
boxes. For example, TBP might have higher affinity for the
HSP70TATA box than for the others examined in our studies.
The probability that T antigen would encounter the TBP
bound to the HSP70TATA box would then be greater than
that it would encounter the TBP bound to the other TATA
boxes used in these experiments. T antigen bound to TBP
could then stimulate recruitment to the transcription complex
of whatever factor is rate limiting.
When we examined the ability of a set of mutant T antigens
to activate these modular promoters, we focused on several
mutants with lesions in the N-terminal half of T antigen.
Previously, we showed that these mutants activate the SV40
late promoter, the RSV LTR promoter, or both less efficiently
than did the wild-type T antigen (68). Each of the mutants
examined here (Fig. 3) activated each of the promoters tested
to about the same fraction of the level of activation achieved
with wild-type large T antigen. While it is likely that T antigen
activates different cellular promoters by different mechanisms,
reflecting T antigen's interactions with a multiplicity of tran-
scription factors and other proteins, we think it is likely that the
mechanism of activation of these modular promoters is similar
or identical. Had different mutants displayed high levels of
activation on some promoters and low levels on others, this
would have been more consistent with multiple mechanisms of
activation of different simple promoters. Gruda et al. showed
that T antigen interacts with the TBP through sequences within
the first 172 aa of the large T antigen (27). Most of the
mutations that reduced the transcriptional activation activity of
large T antigen are located within this region. In particular,
three of T antigen mutants tested showed absolutely no
activation of any of the promoters tested (47, 68). These are
mutants d1A2411 (lacking aa 143 to 146), inA2815 (insertion at
aa 168), and 187HR (substitution of His for Arg-187; reference
53). It is possible that these three mutations prevent interac-
tion between T antigen and the TBP. This hypothesis is being
tested.
While T antigen is known to activate expression of some
cellular genes, it is not known for most of these genes whether
this activation is direct or indirect. Most likely, a diverse set of
mechanisms underlie changes in cellular gene expression fol-
lowing SV40 infection. Since T antigen forms complexes with
plO5Rb resulting in dissociation of transcription factor E2F,
expression of cellular genes responsive to E2F is likely to be
affected by T antigen binding to plO5Rb. E2F sites are found
in many of the genes induced by serum and by T antigen. Other
transcription factors are likely to form complexes with proteins
to which T antigen binds, and it is expected that expression of
genes responsive to these factors would be induced when T
antigen binds the cellular protein to which these factors bind.
In some cases, formation of multiprotein complexes containing
T antigen may give those complexes enhanced transcriptional
activity because of the presence of large T antigen. Still other
cellular genes may be induced by T antigen as a consequence
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of T antigen binding to tumor suppressor proteins which
normally repress expression of those genes. Roles for both p53
and plO5Rb in transcriptional repression have been reported
(28, 35, 36).
Evidence that T antigen participates directly in transcrip-
tional activation comes from in vitro studies with the SV40 late
(I17) and human HSP70 (56) promoters. The most likely
primary target for direct transcriptional stimulation by T
antigen is the SV40 late promoter. Late in infection, this
promoter is transcribed from amplified viral templates to
produce high levels of SV40 late mRNAs. T antigen also binds
transcription factor TEF-1 (27). Since TEF-1-binding sites are
important for SV40 late transcription (12, 15, 24, 26, 34, 42), T
antigen-TEF-l interactions could play a role in making the
SV40 late promoter a particularly good substrate for T antigen
activation. The SV40 late promoter lacks a TATA box, but
among sequences surrounding the major late transcription
initiation site at nt 325 and important for late transcription are
some which resemble Inr elements. The TBP is known to be
important for in vitro transcription of promoters which lack
obvious TATA boxes (12, 15, 24, 26, 34, 42) and may also bind
directly to Inr elements (65).
We suggest that an additional mechanism of transcriptional
activation by T antigen could involve the chromosomal status
of the DNA. The only episomal DNA present during an SV40
infection is SV40 DNA. All of the reporter genes which we
have examined were part of episomal DNA molecules. If T
antigen's activities in transcriptional activation were directed in
some manner towards episomal DNA, the normal conse-
quences of this rather non-gene-specific mechanism would be
increased transcription from the promoters present in the
SV40 genome. Since large T antigen directly represses tran-
scription of the SV40 early promoter, the SV40 late promoter
would be the promoter most stimulated by such a mechanism.
We conducted a preliminary experiment to examine how T
antigen affects episomal versus chromosomal genes. We iso-
lated a cell line containing a stably integrated RSV-luciferase
reporter by transfecting cells with an RSV-luciferase construct
and pSV2NEO and screened many G418-resistant clones to
find any that expressed even a basal level of luciferase. One
such cell line was cotransfected with RSV-CAT and a plasmid
that encodes SV40 large T antigen. We found that the CAT
level was stimulated by T antigen (compared with transfection
of the same cell line with RSV-CAT alone), while the level of
luciferase was reduced when T antigen was present (47).
Additional experiments are required to confirm and extend
this finding.
Whether or not nucleosomes are present over the promoter
of a particular gene is an important factor for transcriptional
activation, since nucleosomes are known to prevent transcrip-
tion of some genes. Some, but not all, transcriptional activators
are able to cause displacement of nucleosomes, a requirement
for activation of some promoters when they are present within
cellular chromatin but not when they are introduced into cells
by transient transfection (3). The studies described here indi-
cate that T antigen is able to activate a wide variety of
promoters carried on episomal DNA molecules. The mecha-
nism for this activation is likely to be important for understand-
ing how T antigen stimulates the SV40 late promoter.
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